Gastrointestinal tract inflammatory diseases

In patients whose maldigestion is difficult to control, other underlying conditions should be considered, such as noncompliance, infections of the gastrointestinal tract, celiac disease, lactose deficiency, inflammatory bowel disease, anatomical abnormalities, diabetes, and liver cirrhosis. This question is complicated by the abundance of small intestinal viscous glycoproteins in cystic fibrosis, prolonged intestinal transit times, which may provoke bacterial overgrowth [104], and absorption of the enzymes in their macromolecular form [105]. 

These drugp are contraindicated in patients with known hypersensitivity to die drugs, asthma, peptic ulcer disease, coronary artery disease, and hyperthyroidism. Bethanecol is contraindicated in those with mechanical obstruction of die gastrointestinal or genitourinary tracts. Fhtients with secondary glaucoma, iritis, corneal abrasion, or any acute inflammatory disease of the eye should not use die ophtiialmic cholinergic preparations. 

O Inflammatory bowel disease includes both ulcerative colitis and Crohn s disease and is associated with inflammation of various areas of the gastrointestinal tract. 

Indications for use of parenteral iron, e.g. as fer-rioxidesaccharate or iron dextran, are in patients on hemodialysis and patients with a disease which prevents absorption from the gastrointestinal tract, in patients who are on long term parenteral nutrition and sometimes in patients with inflammatory bowel disease. Parenteral iron does not raise the hemoglobin level significantly faster than oral therapy and carries a risk of severe adverse reactions. Reactions to intravenous iron include headache, malaise, fever, arthralgias, urticaria and in rare cases anaphylactic reactions, which may be fatal. 

Bethanechol should not be used in patients with possible mechanical obstruction of the bladder or gastrointestinal tract or when contraction of smooth muscles in these tissues may be harmful (e.g., recent intestinal resection). It is also contraindicated in patients with bronchial asthma, peptic ulcer disease, coronary artery disease, gastrointestinal hypermotility or inflammatory disease, hypotension or marked bradycardia, hyperthyroidism, parkinsonism, or epilepsy. Care should be exercised in administering pilocarpine to elderly patients because it can enter the CNS and affect memory and cognition, even when applied topically to the eye. 

Eosinophils are leukocytes that contain characteristic cationic proteins in their granules that bind the acidic dye eosin. In contrast to neutrophils, eosinophils are minority cells in the blood and are predominantly tissue-dwelling cells found at sites in contact with the environment the mucosal surfaces of the lung, gastrointestinal tract, and genitourinary tract. Selective accumulation of eosinophils, as opposed to neutrophils, is one of the major pathological features of the inflammatory response to infection with parasitic helminths, and in several diseases such as asthma, allergic rhinitis, and atopic dermatitis. A key step in leukocyte recruitment is the local production of chemoattractant molecules that orchestrate the adhesive interactions between leukocytes and the vascular endothelium. 

Local formulations of budesonide are used in the management of inflammatory bowel disease. In mild to moderate Crohn s disease it is given by mouth as modified release capsules intended for a topical effect on the gastrointestinal tract. This approach offers new hope for Crohn s disease sufferers. 

Ulcerative colitis is an inflammatory disease of the lower gastrointestinal tract, which results in episodes of diarrhoea. There may also be extraintestinal symptoms, including anaemia, arthritis, dermatological problems and eye disorders. 

DRUGS ACTING ON THE GASTROINTESTINAL TRACT DRUGS USED TO TREAT INFLAMMATORY BOWEL DISEASE Infliximab... 

Inflammatory bowel disease (ulcerative colitis and Crohn s disease) is a general term for a group of chronic inflammatory disorders of unknown cause involving the gastrointestinal tract. Despite many attempts to confirm an infectious agent as the cause of disease, no bacterial. 

Inflammatory bowel disease is divided into two major gastrointestinal disorders ulcerative colitis (UC) and Crohn s disease. Both diseases are chronic and tend to be characterized by periods of exacerbations and remissions. Major differences between UC and Crohn s disease are differentiated by anatomic location and distribution. UC occurs in the colon and rectum, whereas Crohn s disease can occur throughout the gastrointestinal tract. UC tends to be continuous, diffuse, and mucosal Crohn s appears segmental, focal, and transmural. Fissures, strictures, abdominal masses, and pain are commonly associated with Crohn s. Classical symptoms of UC include chronic diarrhea with tenesmus, rectal bleeding, and abdominal pain. 

Crohn s disease A chronic inflammatory disease of the gastrointestinal tract, which leads to colitis, cryostat An instrument used to cut very thin slices of specimens, e.g. tissues. 

Nitric oxide-releasing NSAlDs, such as NO-aspirin 50 (NCX-4016) and the ibuprofen derivative 51, contain a cleavable ester linker to a nitric oxide-releasing moiety (Figure 27.12). It was hoped that this dual activity would translate into a superior anti-inflammatory and antithrombotic profile in patients with cardiovascular diseases, whilst sparing the gastrointestinal tract. 

There are two forms of idiopathic inflammatory bowel disease (IBD) (a) ulcerative colitis, a mucosal inflammatory condition confined to the rectum and colon and (b) Crohn s disease, a transmural inflammation of the gastrointestinal tract that can affect any part, from the mouth to the anus. The etiologies of both conditions are unknown, but they may have some common pathogenetic mechanisms. 

Inflammatory diseases of the gastrointestinal tract discharge mucus, serum proteins, and blood into the gut. Sometimes bowel movements consist only of mucus, exudate, and blood. Exudative diarrhea probably affects other absorptive, secretory, or motility functions to account for the large stool volume associated with this disorder. 

Inflammatory bowel diseases (IBD) are chronic inflammatory conditions which affect the gastrointestinal tract. They are characterized by a localized or diffuse granulomatous inflammatory process, accompanied by systemic manifestations. As ulceration and regeneration of the intestinal epithelium occurs during the course of the disease, angiogenesis is undoubtedly an integral part of the IBD pathology [148]. 

CEA is expressed in a variety of carcinomas, particularly of the gastrointestinal tract (e.g., Crohn s disease, inflammatory bowel disease, post-radiation therapy to the bowel) and can be detected in the serum. lMMU-4 is specific for the classical 200000-Da CEA that is found predominantly on the cell membrane. " Tc-CEA-Scan complexes the circulating CEA and binds to CEA on the cell surface. Imaging efficacy and safety have been evaluated in four clinical trials to evaluate the presence, location, and extent of colorectal cancer, primarily in the liver and extrahepatic abdominal and pelvic regions. 

The idiopathic inflammatory bowel disease includes ulcerative colitis and granulomatous disease of the gastrointestinal tract (Crohn s disease). The newer derivatives of 5-aminosalicylic acid, namely balsalazine, sulfasalazine, or olsalazine, may be effective for treating ulcerative colitis but not Crohn s disease. 

---